Signal transduction pathways alter the molecular cargo of extracellular vesicles: implications in regenerative medicine.

IF 2.4 4区医学 Q4 CELL & TISSUE ENGINEERING Regenerative medicine Pub Date : 2023-12-01 Epub Date: 2023-12-07 DOI:10.2217/rme-2023-0183

Prajakta Teli, Anuradha Vaidya, Vaijayanti Kale

引用次数: 0

Abstract

Extracellular vesicles (EVs) possess regenerative properties and are also considered as future vaccines. All types of cells secrete EVs; however, the amount of EVs secreted by the cells varies under various physiological as well as pathological states. Several articles have reviewed the molecular composition and potential therapeutic applications of EVs. Likewise, the 'sorting signals' associated with specific macromolecules have also been identified, but how the signal transduction pathways prevailing in the parent cells alter the molecular profile of the EVs or the payload they carry has not been sufficiently reviewed. Here, we have specifically discussed the implications of these alterations in the macromolecular cargo of EVs for their therapeutic applications in regenerative medicine.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

信号转导通路改变细胞外囊泡的分子货物:在再生医学中的意义。

细胞外囊泡(EVs)具有再生特性，也被认为是未来的疫苗。所有类型的细胞都分泌ev;然而，在不同的生理和病理状态下，细胞分泌的ev数量是不同的。一些文章综述了ev的分子组成和潜在的治疗应用。同样，与特定大分子相关的“分类信号”也已被确定，但在亲本细胞中普遍存在的信号转导途径如何改变ev的分子特征或它们携带的有效载荷尚未得到充分的审查。在这里，我们特别讨论了电动汽车大分子货物中这些改变对其在再生医学中的治疗应用的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Regenerative medicine 医学-工程：生物医学

CiteScore

4.20

自引率

3.70%

发文量

审稿时长

6-12 weeks

期刊介绍： Regenerative medicine replaces or regenerates human cells, tissue or organs, to restore or establish normal function*. Since 2006, Regenerative Medicine has been at the forefront of publishing the very best papers and reviews covering the entire regenerative medicine sector. The journal focusses on the entire spectrum of approaches to regenerative medicine, including small molecule drugs, biologics, biomaterials and tissue engineering, and cell and gene therapies – it’s all about regeneration and not a specific platform technology. The journal’s scope encompasses all aspects of the sector ranging from discovery research, through to clinical development, through to commercialization. Regenerative Medicine uniquely supports this important area of biomedical science and healthcare by providing a peer-reviewed journal totally committed to publishing the very best regenerative medicine research, clinical translation and commercialization. Regenerative Medicine provides a specialist forum to address the important challenges and advances in regenerative medicine, delivering this essential information in concise, clear and attractive article formats – vital to a rapidly growing, multidisciplinary and increasingly time-constrained community. Despite substantial developments in our knowledge and understanding of regeneration, the field is still in its infancy. However, progress is accelerating. The next few decades will see the discovery and development of transformative therapies for patients, and in some cases, even cures. Regenerative Medicine will continue to provide a critical overview of these advances as they progress, undergo clinical trials, and eventually become mainstream medicine.